Nearly one in nine people in Czechia received treatment for diabetes last year, and doctors expect the number to reach 1.3 million by 2030.
The country recorded approximately 1.16 million patients in 2025, up from 913,000 in 2020. Healthcare spending on these patients reached CZK 154 billion—roughly twice the amount five years earlier.
That figure covers their overall medical care, including heart disease, eye conditions and other complications, rather than treatment of diabetes alone, the Czech Diabetes Society said Wednesday.
Earlier intervention could prevent costly complications
Even action taken now may not immediately reverse the trend, society chairman Martin Prázný warned.
“Even if we do something now, momentum could keep the numbers rising for another 10 or 20 years,” he said.
Doctors are therefore focusing increasingly on people who have not developed diabetes but face an elevated risk of doing so within several years.
Centralized blood-test results analyzed by the Institute of Health Information and Statistics have identified approximately 360,000 such people in Czechia.
If they develop diabetes without effective intervention, their care could cost approximately CZK 18 billion annually, Prázný estimated.
The aim is to direct more resources toward earlier stages of disease and subsequently reduce spending on complications.
Type 2 diabetes accounts for most cases. Diet and physical activity are important factors in its development and management, and Prázný said treating accompanying obesity was also an important part of care.
Total healthcare spending on people with diabetes represented approximately 29 percent of the CZK 530 billion handled by public health insurance last year.
Heart and eye problems add to the burden
The consequences extend well beyond blood sugar levels.
Diabetologist David Karásek of Olomouc University Hospital said approximately one-third of patients had a cardiovascular condition. Heart failure was four times more common among people with diabetes than in the population without it.
Eye complications are another concern. According to Prázný, approximately 40 percent of patients had not attended an ophthalmologist who could identify retinal changes early.
Some diabetes specialists can now screen patients’ eyes using dedicated imaging equipment, with artificial intelligence assessing the images.
Over three years, screening detected more than 18,000 previously unidentified patients with diabetic retinopathy, he said.
The condition affects the retina and is among the complications doctors are seeking to detect before more serious damage develops.
For information about the condition and its treatment, the Czech National Health Information Portal provides an overview of type 2 diabetes.





